Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Equity

v3.20.1
Condensed Statements of Stockholders' Equity - USD ($)
Common Shares [Member]
Common Stock Issuable [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Class A Common Shares [Member]
Total
Balances at Dec. 31, 2018 $ 3,000 $ 1,748,000 $ 105,451,000 $ (95,397,000) $ 1,000 $ 11,806,000
Balances (in Shares) at Dec. 31, 2018 27,076,154       7,000,000  
Issuance of common shares, net of offering costs - At-the-market offering $ 0 0 355,000 0 $ 0 355,000
Issuance of common shares, net of offering costs - At-the-market offering (in Shares) 90,269       0  
Stock-based compensation expense $ 0 0 798,000 0 $ 0 798,000
Stock-based compensation expense (in Shares) 713,000       0  
Issuance of common shares - Founders Agreement $ 0 (1,748,000) 1,757,000 0 $ 0 9,000
Issuance of common shares - Founders Agreement (in Shares) 962,682       0  
Exercise of warrants $ 0 0 0 0 $ 0 0
Exercise of warrants (in Shares) 39,651       0  
Net loss $ 0 0 0 (5,890,000) $ 0 (5,890,000)
Balances at Mar. 31, 2019 $ 3,000 0 108,361,000 (101,287,000) $ 1,000 7,078,000
Balances (in Shares) at Mar. 31, 2019 28,881,756       7,000,000  
Balances at Dec. 31, 2019 $ 5,000 2,510,000 136,442,000 (120,111,000) $ 1,000 18,847,000
Balances (in Shares) at Dec. 31, 2019 47,004,764       7,000,000  
Stock-based compensation expense $ 0 0 639,000 0 $ 0 639,000
Stock-based compensation expense (in Shares) 931,000       0  
Exercise of warrants $ 0 0 13,000 0 $ 0 13,000
Exercise of warrants (in Shares) 102,742       0  
Net loss $ 0 0 0 (3,281,000) $ 0 (3,281,000)
Balances at Mar. 31, 2020 $ 5,000 $ 2,510,000 $ 137,094,000 $ (123,392,000) $ 1,000 $ 16,218,000
Balances (in Shares) at Mar. 31, 2020 48,038,506       7,000,000